Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial
- Citation:
- JCO Precis Oncol vol 6
- Year:
- 2022
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub-ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 11
- Parents:
- 2819
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Frank A. Sinicrope Qian Shi Aurelie Catteau Graham M. Poage Tyler J. Zemla Bernhard Mlecnik Al B. Benson Sharlene Gill Richard M. Goldberg Morton S. Kahlenberg Suresh G. Nair Anthony F. Shields Thomas C. Smyrk Jerome Galon Steven R. Alberts
- Networks:
- Study
- NCCTG-N0147
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: